SCHEMBL6513329

SCHEMBL6513329

CCCCc1ccc(N=C(N)Nc2cc(C)cc(C)n2)c(C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.53
RAB9A P51151 2/20 0.53
CYP2D6 P10635 3/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 1/20 0.46
CYP4Z1 Q86W10 1/20 0.46
CYP4F11 Q9HBI6 1/20 0.46
CYP4F12 Q9HCS2 1/20 0.46
SKP2 Q13309 1/20 0.40
SIGMAR1 Q99720 5/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
PHGDH O43175 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GRIN2D O15399 2/20 0.36
GRIN3B O60391 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6510224 0.87 RAB9A (0.50) MAPK1RAB9ACYP2D6CYP3A4CYP2C9
SCHEMBL6510696 0.85 RAB9A (0.59) MAPK1RAB9ACYP2D6CYP3A4CYP2C9
SCHEMBL6507381 0.81 RAB9A (0.54) MAPK1RAB9AMEN1KMT2APHGDH
SCHEMBL5923622 0.75 MEN1 (0.43) MAPK1RAB9ACYP2D6CYP3A4CYP2C9
SCHEMBL5923669 0.70 MAPK1 (0.43) MAPK1RAB9AMEN1KMT2APHGDH
SCHEMBL15938854 0.68 RAC1 (0.67) SIGMAR1PHGDHALDH1A1LMNAGRIN2D
SCHEMBL5923410 0.68 MAPK1 (0.48) MAPK1RAB9AMEN1KMT2ALMNA
SCHEMBL6511078 0.67 GRIN2D (0.43) MAPK1CYP2D6CYP3A4CYP2C9CYP1A2
SCHEMBL6515320 0.66 SIGMAR1 (0.46) MAPK1RAB9ACYP2D6CYP1A2SIGMAR1
SCHEMBL6510332 0.65 KMT2A (0.55) RAB9ASIGMAR1MEN1KMT2APHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed